investor harm

Class action lawsuit filed against Corcept Therapeutics alleging executives made false statements about relacorilant's clinical strength and FDA approval prospects.

Class action filed against NUAI alleging material misstatements on Texas data centers project and New Mexico oil operations. Investors from Nov 2024-Dec 2025 eligible.

Class action lawsuit filed against $UHG alleging false statements and failure to disclose controlling shareholder's intent to force company sale.

Class action lawsuit filed against $APO alleging leadership made false statements about Jeffrey Epstein relationship, harming investors between May 2021 and February 2026.

Class action lawsuit filed against $NKTR alleging false statements about REZOLVE-AA trial enrollment and integrity. Lead plaintiff deadline set for May 5, 2026.

Class action lawsuit filed against $MDPC alleging executives overstated book-to-bill ratio at approximately 1.15 despite contrary internal data from April 2025 to February 2026.

Aquestive Therapeutics faces class action lawsuit alleging securities fraud over false FDA approval statements and concealed anaphylaxis product risks.

Class action lawsuit filed against Gossamer Bio for alleged false statements regarding Phase 3 PROSERA study results and concealed trial design issues at Latin American sites.

NuScale Power faces a class action lawsuit alleging securities fraud over misrepresentations about partner ENTRA1's nuclear experience, threatening investor confidence in the SMR sector.

AMC faces class action lawsuit alleging securities fraud over APE unit dividend exclusion, potentially affecting investors who purchased units between August 2022 and November 2023.

Class action lawsuit filed against $TCOM alleging securities fraud over false regulatory risk statements from April 2024 to January 2026.

Class action lawsuit filed against Alight alleging executives made false statements on CEO transition, capital returns, and revenue targets. Investors have until May 15, 2026 to join.

Class action lawsuit filed against Concorde International Group alleging securities fraud, false statements, and coordinated insider stock dumping during April-July 2025.

Class action lawsuit filed against $EOSE alleging securities fraud over undisclosed production delays, battery downtime, and quality control failures.

Class action lawsuit filed against $MNDY alleging materially false statements about revenue growth and concealed business deterioration.

Class action lawsuit filed against PSIX alleging materially false statements regarding data center sales and manufacturing capacity costs between May 2025 and March 2026.

Class action lawsuit filed against $LAKE alleging executives made false statements about Pacific Helmets and Jolly businesses while concealing operational issues between December 2023 and December 2025.

Stellantis faces class action lawsuit alleging false statements on earnings forecasts, electrification strategy. Investors can join until June 8, 2026.

Class action filed against $POM alleging false statements, fraudulent social media promotion, insider share dumping via offshore accounts, and artificial trading activity during Oct-Dec 2025.

Class action filed against Nektar Therapeutics alleging false trial statements regarding REZOLVE-AA enrollment. Lead plaintiff deadline: May 5, 2026.